Agenzie

(MedPage Today) -- Study is first to explore event-related sleep issues

The World Health Organization will convene its emergency committee on Friday June 14 to decide whether the Ebola outbreak constitutes an international emergency, the U.N. agency said in a statement.

(MedPage Today) -- Roundup of further analyses from ADA 2019

Congo's government has declared an epidemic of measles, which the latest health ministry figures show has now killed at least 1,500 people, over a hundred more than have died of Ebola.

Catalyst Pharmaceuticals Inc, which has come under fire for the high price tag on its rare disease drug, on Wednesday sued the U.S. Food and Drug Administration to challenge the recent approval of a lower-cost rival drug.

(MedPage Today) -- The Skeptical Cardiologist tackles the "most important meal of the day"

(Reuters Health) - U.S. health officials warned pet-owners against kissing and snuggling their hedgehogs as a Salmonella outbreak linked to contact with the animals spread to 17 states.

(MedPage Today) -- Despite sub-optimal care Europeans have limited complaints

Catalyst Pharmaceuticals Inc said on Wednesday it has filed a lawsuit against the U.S. Food and Drug Administration, challenging the recent approval of Jacobus Pharmaceutical Co's drug, Ruzurgi, for a rare neuromuscular disease.

A five-year-old boy is the first death confirmed in Uganda, after hundreds died in DR Congo.

(MedPage Today) -- Authors offer more precise definitions for non-alcoholic and alcoholic fatty liver disease; stress overlap between the two

(MedPage Today) -- TVT Registry to start collecting data on technique's use

(MedPage Today) -- The main supporting trial used a product not readily available

Rare diseases specialist Swedish Orphan Biovitrum (Sobi) has agreed to buy the drug emapalumab and is reorganizing to increase focus on late-stage development in hematology and immunology.

(MedPage Today) -- This on-the-ground work is one of the great untold costs of the measles resurgence

Catalyst Pharmaceuticals Inc said on Wednesday it has filed a lawsuit against the U.S. Food and Drug Administration, challenging the recent approval of Jacobus Pharmaceutical Co's drug, Ruzurgi, for a rare neuromuscular disease.

(MedPage Today) -- Unanswered questions about use of palbociclib, ribociclib, and abemaciclib

(MedPage Today) -- This past week in healthcare investigations

Uganda announced two more cases of Ebola on Wednesday - a grandmother and a three-year-old boy, confirming that a deadly outbreak has spread for the first time beyond the Democratic Republic of Congo.

(MedPage Today) -- Hospitalization rates similar to those seen with diabetes